vs
Mativ Holdings, Inc.（MATV）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Mativ Holdings, Inc.的季度营收约是Bio-Techne的1.6倍（$463.1M vs $295.9M），Mativ Holdings, Inc.净利率更高（21.8% vs 12.8%，领先8.9%），Mativ Holdings, Inc.同比增速更快（1.0% vs -6.4%），过去两年Bio-Techne的营收复合增速更高（4.2% vs -3.8%）
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
MATV vs TECH — 直观对比
营收规模更大
MATV
是对方的1.6倍
$295.9M
营收增速更快
MATV
高出7.4%
-6.4%
净利率更高
MATV
高出8.9%
12.8%
两年增速更快
TECH
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $463.1M | $295.9M |
| 净利润 | $100.8M | $38.0M |
| 毛利率 | 18.8% | 64.6% |
| 营业利润率 | 2.2% | 18.4% |
| 净利率 | 21.8% | 12.8% |
| 营收同比 | 1.0% | -6.4% |
| 净利润同比 | 6620.0% | 68.3% |
| 每股收益（稀释后） | $1.87 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MATVTECH
| Q4 25 | $463.1M | $295.9M | ||
| Q3 25 | $513.7M | — | ||
| Q2 25 | $525.4M | $317.0M | ||
| Q1 25 | $484.8M | $316.2M | ||
| Q4 24 | $458.6M | $297.0M | ||
| Q3 24 | $498.5M | $289.5M | ||
| Q2 24 | $523.8M | $306.1M | ||
| Q1 24 | $500.2M | $303.4M |
净利润MATVTECH
| Q4 25 | $100.8M | $38.0M | ||
| Q3 25 | $-3.2M | — | ||
| Q2 25 | $-9.5M | $-17.7M | ||
| Q1 25 | $-425.5M | $22.6M | ||
| Q4 24 | $1.5M | $34.9M | ||
| Q3 24 | $-20.8M | $33.6M | ||
| Q2 24 | $-1.4M | $40.6M | ||
| Q1 24 | $-28.0M | $49.1M |
毛利率MATVTECH
| Q4 25 | 18.8% | 64.6% | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 19.7% | 62.7% | ||
| Q1 25 | 15.0% | 67.9% | ||
| Q4 24 | 16.9% | 65.3% | ||
| Q3 24 | 18.8% | 63.2% | ||
| Q2 24 | 20.8% | 66.4% | ||
| Q1 24 | 16.8% | 67.4% |
营业利润率MATVTECH
| Q4 25 | 2.2% | 18.4% | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.8% | -7.5% | ||
| Q1 25 | -88.8% | 12.2% | ||
| Q4 24 | 0.6% | 16.0% | ||
| Q3 24 | 1.4% | 13.8% | ||
| Q2 24 | 2.0% | 15.0% | ||
| Q1 24 | -2.8% | 22.1% |
净利率MATVTECH
| Q4 25 | 21.8% | 12.8% | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | -1.8% | -5.6% | ||
| Q1 25 | -87.8% | 7.1% | ||
| Q4 24 | 0.3% | 11.7% | ||
| Q3 24 | -4.2% | 11.6% | ||
| Q2 24 | -0.3% | 13.3% | ||
| Q1 24 | -5.6% | 16.2% |
每股收益（稀释后）MATVTECH
| Q4 25 | $1.87 | $0.24 | ||
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $-0.18 | $-0.11 | ||
| Q1 25 | $-7.82 | $0.14 | ||
| Q4 24 | $0.03 | $0.22 | ||
| Q3 24 | $-0.38 | $0.21 | ||
| Q2 24 | $-0.03 | $0.26 | ||
| Q1 24 | $-0.52 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $84.2M | $172.9M |
| 总债务越低越好 | $1.0B | $260.0M |
| 股东权益账面价值 | $498.7M | $2.0B |
| 总资产 | $2.1B | $2.5B |
| 负债/权益比越低杠杆越低 | 2.07× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MATVTECH
| Q4 25 | $84.2M | $172.9M | ||
| Q3 25 | $97.1M | — | ||
| Q2 25 | $95.6M | $162.2M | ||
| Q1 25 | $84.0M | $140.7M | ||
| Q4 24 | $94.3M | $177.5M | ||
| Q3 24 | $162.2M | $187.5M | ||
| Q2 24 | $133.4M | $152.9M | ||
| Q1 24 | $128.9M | $145.3M |
总债务MATVTECH
| Q4 25 | $1.0B | $260.0M | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | $346.0M | ||
| Q1 25 | $1.1B | $330.0M | ||
| Q4 24 | $1.1B | $300.0M | ||
| Q3 24 | $1.2B | $300.0M | ||
| Q2 24 | $1.2B | $319.0M | ||
| Q1 24 | $1.2B | $389.0M |
股东权益MATVTECH
| Q4 25 | $498.7M | $2.0B | ||
| Q3 25 | $397.4M | — | ||
| Q2 25 | $416.6M | $1.9B | ||
| Q1 25 | $428.2M | $2.0B | ||
| Q4 24 | $858.5M | $2.1B | ||
| Q3 24 | $882.3M | $2.1B | ||
| Q2 24 | $898.0M | $2.1B | ||
| Q1 24 | $906.9M | $2.0B |
总资产MATVTECH
| Q4 25 | $2.1B | $2.5B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.4B | $2.7B | ||
| Q3 24 | $2.6B | $2.7B | ||
| Q2 24 | $2.6B | $2.7B | ||
| Q1 24 | $2.7B | $2.7B |
负债/权益比MATVTECH
| Q4 25 | 2.07× | 0.13× | ||
| Q3 25 | 2.63× | — | ||
| Q2 25 | 2.66× | 0.18× | ||
| Q1 25 | 2.67× | 0.16× | ||
| Q4 24 | 1.30× | 0.14× | ||
| Q3 24 | 1.32× | 0.14× | ||
| Q2 24 | 1.29× | 0.15× | ||
| Q1 24 | 1.30× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.3M | — |
| 自由现金流经营现金流 - 资本支出 | $8.0M | — |
| 自由现金流率自由现金流/营收 | 1.7% | — |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | 0.19× | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | — |
8季度趋势，按日历期对齐
经营现金流MATVTECH
| Q4 25 | $19.3M | — | ||
| Q3 25 | $72.8M | — | ||
| Q2 25 | $57.6M | $98.2M | ||
| Q1 25 | $-15.9M | $41.1M | ||
| Q4 24 | $24.1M | $84.3M | ||
| Q3 24 | $37.6M | $63.9M | ||
| Q2 24 | $46.1M | $75.5M | ||
| Q1 24 | $-13.0M | $81.0M |
自由现金流MATVTECH
| Q4 25 | $8.0M | — | ||
| Q3 25 | $66.7M | — | ||
| Q2 25 | $48.9M | $93.3M | ||
| Q1 25 | $-29.8M | $31.0M | ||
| Q4 24 | $2.0M | $77.5M | ||
| Q3 24 | $25.5M | $54.7M | ||
| Q2 24 | $37.4M | $57.5M | ||
| Q1 24 | $-25.1M | $64.5M |
自由现金流率MATVTECH
| Q4 25 | 1.7% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 9.3% | 29.4% | ||
| Q1 25 | -6.1% | 9.8% | ||
| Q4 24 | 0.4% | 26.1% | ||
| Q3 24 | 5.1% | 18.9% | ||
| Q2 24 | 7.1% | 18.8% | ||
| Q1 24 | -5.0% | 21.3% |
资本支出强度MATVTECH
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.7% | 1.5% | ||
| Q1 25 | 2.9% | 3.2% | ||
| Q4 24 | 4.8% | 2.3% | ||
| Q3 24 | 2.4% | 3.2% | ||
| Q2 24 | 1.7% | 5.9% | ||
| Q1 24 | 2.4% | 5.4% |
现金转化率MATVTECH
| Q4 25 | 0.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 16.07× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
